Association between celiac disease and risk of kidney diseases: a systematic review and meta-analysis.

IF 1.9 Q3 GASTROENTEROLOGY & HEPATOLOGY
Sawai S Rathore, Shifa P Shaikh, Hyder R Zaidi, George O Salako, Chiranjeevee R Saravanan, Rabiat R Kuranga, Narendra Yagateela, Sai T Bandala, Bijay M Jeswani
{"title":"Association between celiac disease and risk of kidney diseases: a systematic review and meta-analysis.","authors":"Sawai S Rathore, Shifa P Shaikh, Hyder R Zaidi, George O Salako, Chiranjeevee R Saravanan, Rabiat R Kuranga, Narendra Yagateela, Sai T Bandala, Bijay M Jeswani","doi":"10.23736/S2724-5985.25.03733-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Celiac disease (CD), an autoimmune disorder, has been linked to chronic kidney disease but results are inconsistent. This meta-analysis investigates the association between CD and the risk of kidney disease.</p><p><strong>Evidence acquisition: </strong>A systematic literature search was conducted using PubMed, Embase, and Google Scholar up to March 31, 2024. Studies included observational reports on CD and kidney diseases. Random-effects models estimated pooled odds ratios (ORs) and 95% confidence intervals (CIs) to report the overall effect size, with significance set at P<0.05. Study quality was assessed using the Newcastle-Ottawa Scale (NCOS). Publication bias was evaluated using Egger's regression and Begg's rank correlation tests.</p><p><strong>Evidence synthesis: </strong>Nine studies with 2022,686 patients were included. The pooled prevalence of overall kidney disease, glomerulonephritis, and end-stage renal disease (ESRD) in CD patients was 2.29% (95% CI 1.34-3.49), 1.31% (95% CI 0.52-2.47), and 1.55% (95% CI 0.11-4.59), respectively. CD was significantly associated with a higher risk of overall kidney disease (OR=1.98, 95% CI 1.48-2.65), glomerulonephritis (OR=2.68, 95% CI 1.54-4.66), and ESRD (OR=2.58, 95% CI 1.32-5.03). Most studies were of high or moderate quality according to NCOS, and no publication bias was detected.</p><p><strong>Conclusions: </strong>CD patients have an elevated risk of various kidney diseases, including glomerulonephritis and ESRD. Monitoring renal function and managing CD are crucial to mitigating potential kidney damage. Future research should investigate the mechanisms underlying this association and explore targeted interventions to prevent or delay renal complications in CD patients.</p>","PeriodicalId":94142,"journal":{"name":"Minerva gastroenterology","volume":" ","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva gastroenterology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23736/S2724-5985.25.03733-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Celiac disease (CD), an autoimmune disorder, has been linked to chronic kidney disease but results are inconsistent. This meta-analysis investigates the association between CD and the risk of kidney disease.

Evidence acquisition: A systematic literature search was conducted using PubMed, Embase, and Google Scholar up to March 31, 2024. Studies included observational reports on CD and kidney diseases. Random-effects models estimated pooled odds ratios (ORs) and 95% confidence intervals (CIs) to report the overall effect size, with significance set at P<0.05. Study quality was assessed using the Newcastle-Ottawa Scale (NCOS). Publication bias was evaluated using Egger's regression and Begg's rank correlation tests.

Evidence synthesis: Nine studies with 2022,686 patients were included. The pooled prevalence of overall kidney disease, glomerulonephritis, and end-stage renal disease (ESRD) in CD patients was 2.29% (95% CI 1.34-3.49), 1.31% (95% CI 0.52-2.47), and 1.55% (95% CI 0.11-4.59), respectively. CD was significantly associated with a higher risk of overall kidney disease (OR=1.98, 95% CI 1.48-2.65), glomerulonephritis (OR=2.68, 95% CI 1.54-4.66), and ESRD (OR=2.58, 95% CI 1.32-5.03). Most studies were of high or moderate quality according to NCOS, and no publication bias was detected.

Conclusions: CD patients have an elevated risk of various kidney diseases, including glomerulonephritis and ESRD. Monitoring renal function and managing CD are crucial to mitigating potential kidney damage. Future research should investigate the mechanisms underlying this association and explore targeted interventions to prevent or delay renal complications in CD patients.

乳糜泻与肾脏疾病风险之间的关系:一项系统综述和荟萃分析。
乳糜泻(CD)是一种自身免疫性疾病,与慢性肾脏疾病有关,但结果不一致。这项荟萃分析调查了乳糜泻与肾脏疾病风险之间的关系。证据获取:截至2024年3月31日,使用PubMed、Embase和谷歌Scholar进行了系统的文献检索。研究包括CD和肾脏疾病的观察性报告。随机效应模型估计了合并优势比(or)和95%置信区间(ci)来报告总体效应大小,显著性设定在证据综合:9项研究纳入了2022例,686例患者。CD患者总体肾脏疾病、肾小球肾炎和终末期肾脏疾病(ESRD)的总患病率分别为2.29% (95% CI 1.34-3.49)、1.31% (95% CI 0.52-2.47)和1.55% (95% CI 0.11-4.59)。CD与整体肾脏疾病(OR=1.98, 95% CI 1.48-2.65)、肾小球肾炎(OR=2.68, 95% CI 1.54-4.66)和ESRD (OR=2.58, 95% CI 1.32-5.03)的高风险显著相关。根据NCOS,大多数研究为高质量或中等质量,未发现发表偏倚。结论:CD患者发生多种肾脏疾病的风险增加,包括肾小球肾炎和终末期肾病。监测肾功能和控制乳糜泻是减轻潜在肾损害的关键。未来的研究应该探讨这种关联的机制,并探索有针对性的干预措施来预防或延缓CD患者的肾脏并发症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.10
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信